Bone Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Bone Cancer, including details on symptoms, types, treatment.

Volume 7 (2010), Issue 11 (November)

1. Metastatic adenocarcinoma after intramedullary fixation of a tibial fracture: A report of two cases.
   J Bone Joint Surg Br, 92(11): 1592-5. [Abstract] [Full-text]
2. The prognosis for patients with osteosarcoma who have received prior manipulative therapy.
   J Bone Joint Surg Br, 92(11): 1580-5. [Abstract] [Full-text]
3. Free vascularised fibular graft for reconstruction of defects of the lower limb after resection of tumour.
   J Bone Joint Surg Br, 92(11): 1574-9. [Abstract] [Full-text]
4. The outcome of pelvic reconstruction with non-vascularised fibular grafts after resection of bone tumours.
   J Bone Joint Surg Br, 92(11): 1568-73. [Abstract] [Full-text]
5. Earlier diagnosis of bone and soft-tissue tumours.
   J Bone Joint Surg Br, 92(11): 1489-92. [Abstract] [Full-text]
6. Costal osteochondroma causing pneumothorax in an adolescent: a case report and review of the literature.
   J Pediatr Surg, 45(11): 2250-3. [Abstract] [Full-text]
7. Preliminary proposal for surgical classification of sacral tumors.
   J Neurosurg Spine, 13(5): 651-8. [Abstract] [Full-text]
8. Skull base tumor model.
   J Neurosurg, 113(5): 1106-11. [Abstract] [Full-text]
9. The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas.
   J Neurosurg, 113(5): 1029-35. [Abstract] [Full-text]
10. The role of radical microsurgical resection in multimodal treatment for skull base meningioma.
    J Neurosurg, 113(5): 1072-8. [Abstract] [Full-text]
11. Clival chordomas: clinical management, results, and complications in 71 patients.
    J Neurosurg, 113(5): 1059-71. [Abstract] [Full-text]
12. The endoscopic, endonasal, transmaxillary transpterygoid approach to the pterygopalatine fossa, infratemporal fossa, petrous apex, and the Meckel cave.
    J Neurosurg, 113(5): 967-74. [Abstract] [Full-text]
13. FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells.
    Biochem Biophys Res Commun, 402(1): 129-34. [Abstract] [Full-text]
14. TopBP1 functions with 53BP1 in the G1 DNA damage checkpoint.
    EMBO J, 29(21): 3723-32. [Abstract] [Full-text]
15. Serum follistatin in patients with prostate cancer metastatic to the bone.
    Clin Exp Metastasis, 27(8): 549-55. [Abstract] [Full-text]
16. Serum follistatin in patients with prostate cancer metastatic to the bone.
    Clin Exp Metastasis, 27(8): 549-55. [Abstract] [Full-text]
17. Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain.
    J Neurosci, 30(44): 14649-56. [Abstract] [Full-text]
18. Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer.
    Urology, 76(5): 1175-81. [Abstract] [Full-text]
19. CT, MR, (18)F-FDG PET/CT, and their combined use for the assessment of mandibular invasion by squamous cell carcinomas of the oral cavity.
    Acta Radiol, 51(10): 1111-9. [Abstract] [Full-text]
20. CT, MR, (18)F-FDG PET/CT, and their combined use for the assessment of mandibular invasion by squamous cell carcinomas of the oral cavity.
    Acta Radiol, 51(10): 1111-9. [Abstract] [Full-text]
21. Metastasis and bone loss: advancing treatment and prevention.
    Cancer Treat Rev, 36(8): 615-20. [Abstract] [Full-text]
22. Metastasis and bone loss: advancing treatment and prevention.
    Cancer Treat Rev, 36(8): 615-20. [Abstract] [Full-text]
23. Metastasis and bone loss: advancing treatment and prevention.
    Cancer Treat Rev, 36(8): 615-20. [Abstract] [Full-text]
24. Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors.
    Hum Pathol, 41(12): 1788-93. [Abstract] [Full-text]
25. Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2.
    Cancer Sci, 101(12): 2554-60. [Abstract] [Full-text]
26. Comprehensive keratin profiling reveals different histopathogenesis of keratocystic odontogenic tumor and orthokeratinized odontogenic cyst.
    Hum Pathol, 41(12): 1718-25. [Abstract] [Full-text]
27. Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors.
    Hum Pathol, 41(12): 1788-93. [Abstract] [Full-text]
28. Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2.
    Cancer Sci, 101(12): 2554-60. [Abstract] [Full-text]
29. Comprehensive keratin profiling reveals different histopathogenesis of keratocystic odontogenic tumor and orthokeratinized odontogenic cyst.
    Hum Pathol, 41(12): 1718-25. [Abstract] [Full-text]
30. Neuropathic pain features in patients with bone metastases referred for palliative radiotherapy.
    J Clin Oncol, 28(33): 4892-7. [Abstract] [Full-text]
31. Cavernous hemangioma of the orbital apex: pathogenetic considerations in surgical management.
    Am J Ophthalmol, 150(6): 764-73. [Abstract] [Full-text]
32. Metastasizing (malignant) ameloblastoma: review of a unique histopathologic entity and report of Mayo Clinic experience.
    J Oral Maxillofac Surg, 68(12): 2962-74. [Abstract] [Full-text]
33. Keratocystic odontogenic tumor (odontogenic keratocyst): preliminary retrospective review of epidemiologic, clinical, and radiologic features of 261 lesions from University of Turin.
    J Oral Maxillofac Surg, 68(12): 2994-9. [Abstract] [Full-text]
34. Multimodal approach to the management of metastatic epidural spinal cord compression (MESCC) due to solid tumors.
    Int J Radiat Oncol Biol Phys, 78(5): 1467-73. [Abstract] [Full-text]
35. Cavernous hemangioma of the orbital apex: pathogenetic considerations in surgical management.
    Am J Ophthalmol, 150(6): 764-73. [Abstract] [Full-text]
36. Metastasizing (malignant) ameloblastoma: review of a unique histopathologic entity and report of Mayo Clinic experience.
    J Oral Maxillofac Surg, 68(12): 2962-74. [Abstract] [Full-text]
37. Keratocystic odontogenic tumor (odontogenic keratocyst): preliminary retrospective review of epidemiologic, clinical, and radiologic features of 261 lesions from University of Turin.
    J Oral Maxillofac Surg, 68(12): 2994-9. [Abstract] [Full-text]
38. Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer.
    J Surg Oncol, 102(7): 852-5. [Abstract] [Full-text]
39. Prognostic significance of downregulated expression of programmed cell death 5 in chondrosarcoma.
    J Surg Oncol, 102(7): 838-43. [Abstract] [Full-text]
40. Desarthrodesis and prosthetic reconstruction of the knee after resection of bone tumors.
    J Surg Oncol, 102(7): 832-7. [Abstract] [Full-text]
41. Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases.
    Int J Cancer, 128(2): 352-60. [Abstract] [Full-text]
42. Increased levels of hypoxia-inducible factor-1α are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma.
    J Orthop Res, 29(1): 143-51. [Abstract] [Full-text]
43. Reconstruction of the proximal humerus by combined use of extracorporeally-irradiated osteochondral graft and free vascularized fibula following resection of Ewing sarcoma.
    J Plast Reconstr Aesthet Surg, 63(12): 2177-80. [Abstract] [Full-text]
44. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.
    Int J Cancer, 128(2): 294-303. [Abstract] [Full-text]
45. Multimodal approach to the management of metastatic epidural spinal cord compression (MESCC) due to solid tumors.
    Int J Radiat Oncol Biol Phys, 78(5): 1467-73. [Abstract] [Full-text]
46. Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases.
    Int J Cancer, 128(2): 352-60. [Abstract] [Full-text]
47. Increased levels of hypoxia-inducible factor-1α are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma.
    J Orthop Res, 29(1): 143-51. [Abstract] [Full-text]
48. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.
    Int J Cancer, 128(2): 294-303. [Abstract] [Full-text]
49. Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases.
    Int J Cancer, 128(2): 352-60. [Abstract] [Full-text]
50. Increased levels of hypoxia-inducible factor-1α are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma.
    J Orthop Res, 29(1): 143-51. [Abstract] [Full-text]
51. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.
    Int J Cancer, 128(2): 294-303. [Abstract] [Full-text]
52. Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases.
    Int J Cancer, 128(2): 352-60. [Abstract] [Full-text]
53. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.
    Int J Cancer, 128(2): 294-303. [Abstract] [Full-text]
54. Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors.
    Am J Surg Pathol, 34(12): 1783-91. [Abstract] [Full-text]
55. Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors.
    Am J Surg Pathol, 34(12): 1783-91. [Abstract] [Full-text]
56. Long-term administration of Wilms tumor-1 peptide vaccine in combination with gemcitabine causes severe local skin inflammation at injection sites.
    Jpn J Clin Oncol, 40(12): 1184-8. [Abstract] [Full-text]
57. Long-term administration of Wilms tumor-1 peptide vaccine in combination with gemcitabine causes severe local skin inflammation at injection sites.
    Jpn J Clin Oncol, 40(12): 1184-8. [Abstract] [Full-text]

© 2004-2011 Bone Cancer Research Today. All Rights Reserved.